Stock Events

Stock Events

Aclaris Therapeutics (ACRS) Q3 2023 Earnings

6NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.48

-0.46

-0.43

-0.41

Details

Expected EPS

-0.48

Actual EPS

-0.41

Surprise EPS

0.07

Surprise Percent

+14.58%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.41 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.